Summary:
- Merck Animal Health, a division of the pharmaceutical company Merck, has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) for their new product, Numevit.
- Numevit is a veterinary medicine used to treat and control parasitic infections in livestock, such as cattle, sheep, and goats.
- The positive opinion from the CVMP is an important step in the regulatory approval process, and it indicates that the product has been evaluated and found to be safe and effective for its intended use in the European Union.